THE SKINCARE EDITIONClearer information. More informed choices.Independent by design
PeptiveloBETA
PEPTIVELO / THE SKINCARE EDITION

Copper Tripeptide-1

A copper-linked peptide used to help keep skin in good condition.

Compare products
Reading the name

The ingredient is one part of a product. The formula is the whole mixture. A number such as 29 or 1 identifies a name; it is not a strength or quality score.

Exact label name: Copper Tripeptide-1

Type of support: Safety assessment

Editorial draft · Qualified scientific review pending.

What it is

A short peptide joined to copper. This is an ingredient name, not a quality score.

Why it is used

Used as a skin-conditioning ingredient: a broad cosmetic role concerned with skin condition and appearance.

What the evidence means

The CIR assessment addresses specified cosmetic identities, uses and concentrations. It is a safety assessment, not a trial showing that a finished serum reduces wrinkles. A full topical efficacy review remains pending.

Precautions and possible reactions

Cosmetic safety conclusions do not extend to injection. FDA separately identifies limited human safety data and potential immune-response risks for compounded injectable GHK-Cu.

Cosmetics can cause irritation or allergic reactions. Check the full ingredient list and follow product directions.

What this means for your comparison

Its presence identifies a copper-peptide ingredient. It does not tell us the results you will get from the whole serum.

Sources checked . Ingredient information is separate from testing a finished serum.

Sources you can check

Multi-Peptide + Copper Peptides US product label The Ordinary · Manufacturer / supplier information · Accessed 2026-10-20
Peptide ingredient identities, functions and safety assessment (2018) Cosmetic Ingredient Review / International Journal of Toxicology · Research / ingredient reference · Accessed 2026-10-20
Allergens in cosmetics: reactions and consumer precautions US Food and Drug Administration · Public health guidance · Accessed 2026-10-19
Compounding substances that may present significant safety risks US FDA · Public health guidance · Accessed 2026-10-20

Found on these recorded labels